HOW ARE NEW VACCINES PRIORITIZED IN LOW-INCOME COUNTRIES? A CASE STUDY OF HUMAN PAPILLOMA VIRUS VACCINE AND PNEUMOCOCCAL CONJUGATE VACCINE IN UGANDA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

WALLACE LAUREN; KAPIRIRI LYDIA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: International Journal of Health Policy and Management Year:2017 | Volume:6 | Issue:12 Page(s): 707-720

Download Full-Text

View:

207

Download:

112

Cites:

Information Journal Paper

Title

HOW ARE NEW VACCINES PRIORITIZED IN LOW-INCOME COUNTRIES? A CASE STUDY OF HUMAN PAPILLOMA VIRUS VACCINE AND PNEUMOCOCCAL CONJUGATE VACCINE IN UGANDA

Author(s)

WALLACE LAUREN | KAPIRIRI LYDIA | Issue Writer Certificate

Keywords

PRIORITY SETTING

NEW VACCINES

HUMAN PAPILLOMA VIRUS (HPV) VACCINE

PNEUMOCOCCAL CONJUGATE VACCINE

Abstract

Background: To date, research on priority-setting for NEW VACCINES has not adequately explored the influence of the global, national and sub-national levels of decision-making or contextual issues such as political pressure and stakeholder influence and power. Using Kapiriri and Martin’s conceptual framework, this paper evaluates PRIORITY SETTING for NEW VACCINES in Uganda at national and sub-national levels, and considers how global priorities can influence country priorities. This study focuses on 2 specific vaccines, the human papilloma virus (HPV) vaccine and the PNEUMOCOCCAL CONJUGATE VACCINE (PCV).Methods: This was a qualitative study that involved reviewing relevant Ugandan policy documents and media reports, as well as 54 key informant interviews at the global level and national and sub-national levels in Uganda. Kapiriri and Martin’s conceptual framework was used to evaluate the prioritization process.Results: PRIORITY SETTING for PCV and HPV was conducted by the Ministry of Health (MoH), which is considered to be a legitimate institution. While respondents described the PRIORITY SETTING process for PCV process as transparent, participatory, and guided by explicit relevant criteria and evidence, the prioritization of HPV was thought to have been less transparent and less participatory. Respondents reported that neither process was based on an explicit PRIORITY SETTING framework nor did it involve adequate representation from the districts (program implementers) or publicity. The PRIORITY SETTING process for both PCV and HPV was negatively affected by the larger political and economic context, which contributed to weak institutional capacity as well as power imbalances between development assistance partners and the MoH.Conclusion: PRIORITY SETTING in Uganda would be improved by strengthening institutional capacity and leadership and ensuring a transparent and participatory processes in which key stakeholders such as program implementers (the districts) and beneficiaries (the public) are involved. Kapiriri and Martin’s framework has the potential to guide PRIORITY SETTING evaluation efforts, however, evaluation should be built into the PRIORITY SETTING process a priori such that information on PRIORITY SETTING is gathered throughout the implementation cycle.

Cites

No record.

References

No record.

Cite

APA: Copy

WALLACE, LAUREN, & KAPIRIRI, LYDIA. (2017). HOW ARE NEW VACCINES PRIORITIZED IN LOW-INCOME COUNTRIES? A CASE STUDY OF HUMAN PAPILLOMA VIRUS VACCINE AND PNEUMOCOCCAL CONJUGATE VACCINE IN UGANDA. INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 6(12), 707-720. SID. https://sid.ir/paper/338389/en

Vancouver: Copy

WALLACE LAUREN, KAPIRIRI LYDIA. HOW ARE NEW VACCINES PRIORITIZED IN LOW-INCOME COUNTRIES? A CASE STUDY OF HUMAN PAPILLOMA VIRUS VACCINE AND PNEUMOCOCCAL CONJUGATE VACCINE IN UGANDA. INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT[Internet]. 2017;6(12):707-720. Available from: https://sid.ir/paper/338389/en

IEEE: Copy

LAUREN WALLACE, and LYDIA KAPIRIRI, “HOW ARE NEW VACCINES PRIORITIZED IN LOW-INCOME COUNTRIES? A CASE STUDY OF HUMAN PAPILLOMA VIRUS VACCINE AND PNEUMOCOCCAL CONJUGATE VACCINE IN UGANDA,” INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, vol. 6, no. 12, pp. 707–720, 2017, [Online]. Available: https://sid.ir/paper/338389/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops